Creative Biolabs-Immuno-oncology

Anti-MERTK (clone M3) SynExpress C-Cy3-AR-X Modified CD8+ T cells (CAT#: ITS-1224-CR1105)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target MERTK (clone M3). We employs the pUC (CMV-Cy3-AR-XbaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
MERTK
Clone
M3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
AR
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
pUC
Transformation Accuracy
0.87
Cell Culture
Plate Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.